Short Interest in XOMA Co. (NASDAQ:XOMAP) Decreases By 50.4%

XOMA Co. (NASDAQ:XOMAP) saw a significant drop in short interest in June. As of June 30th, there was short interest totaling 276 shares, a drop of 50.4% from the June 15th total of 556 shares. Based on an average daily trading volume, of 3,957 shares, the short-interest ratio is presently 0.1 days.

XOMA Stock Performance

Shares of NASDAQ XOMAP traded up $0.01 during trading on Wednesday, reaching $24.99. The company had a trading volume of 362 shares, compared to its average volume of 2,224. XOMA has a twelve month low of $24.93 and a twelve month high of $30.00. The stock has a 50-day moving average price of $25.34 and a two-hundred day moving average price of $25.89.

XOMA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a dividend of $0.5391 per share. This represents a $2.16 dividend on an annualized basis and a yield of 8.6%. The ex-dividend date was Thursday, July 2nd.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.